Cavalcanti, E. B. (2022). Equity research of novo Nordisk - a shift in focus: From insulin to GLP-1.
Chicago Style (17th ed.) CitationCavalcanti, Eduardo Burguet. Equity Research of Novo Nordisk - a Shift in Focus: From Insulin to GLP-1. 2022.
MLA (8th ed.) CitationCavalcanti, Eduardo Burguet. Equity Research of Novo Nordisk - a Shift in Focus: From Insulin to GLP-1. 2022.
Warning: These citations may not always be 100% accurate.